TALK Quote, Financials, Valuation and Earnings

Health Catalyst, Inc. has a net margin of 7.56% compared to Talkspace, Inc.'s net margin of -29.13%. Talkspace, Inc.'s return on equity of 6.84% beat Health Catalyst, Inc.'s return on equity of -30.29%.

Talkspace, Inc. has a consensus price target of $6.50, signalling upside risk potential of 31.85%. On the other hand Health Catalyst, Inc. has an analysts' consensus of $3.88 which suggests that it could grow by 130.66%. Given that Health Catalyst, Inc. has higher upside potential than Talkspace, Inc., analysts believe Health Catalyst, Inc. is more attractive than Talkspace, Inc..

Talkspace, Inc. has a beta of 1.176, which suggesting that the stock is 17.627% more volatile than S&P 500. In comparison Health Catalyst, Inc. has a beta of 1.764, suggesting its more volatile than the S&P 500 by 76.444%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Health Catalyst, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $63M, which are smaller than Health Catalyst, Inc. quarterly revenues of $76.3M. Talkspace, Inc.'s net income of $4.8M is higher than Health Catalyst, Inc.'s net income of -$22.2M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 108.83x while Health Catalyst, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 3.70x versus 0.36x for Health Catalyst, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group, Inc. has a net margin of 7.56% compared to Talkspace, Inc.'s net margin of 6.82%. Talkspace, Inc.'s return on equity of 6.84% beat Pediatrix Medical Group, Inc.'s return on equity of 19.95%.

Talkspace, Inc. has a consensus price target of $6.50, signalling upside risk potential of 31.85%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 9.01%. Given that Talkspace, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Talkspace, Inc. is more attractive than Pediatrix Medical Group, Inc..

Talkspace, Inc. has a beta of 1.176, which suggesting that the stock is 17.627% more volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.786, suggesting its less volatile than the S&P 500 by 21.358%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $63M, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $493.8M. Talkspace, Inc.'s net income of $4.8M is lower than Pediatrix Medical Group, Inc.'s net income of $33.7M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 108.83x while Pediatrix Medical Group, Inc.'s PE ratio is 10.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 3.70x versus 0.87x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Marpai, Inc. has a net margin of 7.56% compared to Talkspace, Inc.'s net margin of -86.55%. Talkspace, Inc.'s return on equity of 6.84% beat Marpai, Inc.'s return on equity of --.

Talkspace, Inc. has a consensus price target of $6.50, signalling upside risk potential of 31.85%. On the other hand Marpai, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Talkspace, Inc. has higher upside potential than Marpai, Inc., analysts believe Talkspace, Inc. is more attractive than Marpai, Inc..

Talkspace, Inc. has a beta of 1.176, which suggesting that the stock is 17.627% more volatile than S&P 500. In comparison Marpai, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marpai, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Marpai, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $63M, which are larger than Marpai, Inc. quarterly revenues of $4M. Talkspace, Inc.'s net income of $4.8M is higher than Marpai, Inc.'s net income of -$3.5M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 108.83x while Marpai, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 3.70x versus 0.35x for Marpai, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Universal Health Services, Inc. has a net margin of 7.56% compared to Talkspace, Inc.'s net margin of 9.98%. Talkspace, Inc.'s return on equity of 6.84% beat Universal Health Services, Inc.'s return on equity of 21.28%.

Talkspace, Inc. has a consensus price target of $6.50, signalling upside risk potential of 31.85%. On the other hand Universal Health Services, Inc. has an analysts' consensus of $250.41 which suggests that it could grow by 21.31%. Given that Talkspace, Inc. has higher upside potential than Universal Health Services, Inc., analysts believe Talkspace, Inc. is more attractive than Universal Health Services, Inc..

Talkspace, Inc. has a beta of 1.176, which suggesting that the stock is 17.627% more volatile than S&P 500. In comparison Universal Health Services, Inc. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.165%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Health Services, Inc. offers a yield of 0.39% to investors and pays a quarterly dividend of $0.20 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Universal Health Services, Inc. pays out 3.46% of its earnings as a dividend. Universal Health Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Talkspace, Inc. quarterly revenues are $63M, which are smaller than Universal Health Services, Inc. quarterly revenues of $4.5B. Talkspace, Inc.'s net income of $4.8M is lower than Universal Health Services, Inc.'s net income of $447.8M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 108.83x while Universal Health Services, Inc.'s PE ratio is 8.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 3.70x versus 0.77x for Universal Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.